Electrochemical disinfection of bilge water
Bilge water is the water that accumulates in the lowest parts of a vessel. It may contain seawater, fuel residues, lubricants, cleaning chemicals, antifouling compounds, trace metals and organic matter from tanks, machinery and washdown. The mixture is biologically variable: low temperatures and salt can suppress some organisms, while nutrients, favourable temperature and protected storage can preserve others. A bilge discharge can therefore carry both chemical pollution and viable microorganisms beyond the ship.
ElectroSAnMBR is a Horizon 2020 research project developing a submerged anaerobic electrochemical membrane bioreactor that combines electrolysis, anaerobic digestion and membrane technology to remove oils, chemicals and biodegradable organic pollutants. Within this treatment train, electrochemical disinfection of bilge water targets the inactivation of marine bacteria and pathogens. Australian operators and laboratories can contribute to proving whether this approach works reliably across variable marine chemistry.
Why Australian waters change the risk profile
Port activity creates many small, repeated discharge decisions. Sydney Harbour, the Port of Melbourne, Port of Brisbane and Fremantle support ferries, fishing fleets, tourism vessels, cargo ships and offshore supply vessels, alongside a large recreational boating market. Their bilge streams differ because vessels range from small cruisers to ocean-going ships. This diversity makes Australia a demanding test environment rather than a single, uniform coastal case.
On a recreational vessel, routine activities such as pumping the bilge, rinsing the deck near fuel docks and storing used washwater can change what enters the system. Commercial operators also face pressure to reduce fuel use, labour, space and maintenance. In northern ports, warm water may increase biological growth; in southern waters, lower temperatures can slow reactions but also change oxidant demand. Salinity, turbidity and oily contamination fluctuate with each voyage and weather event.
Compliance is usually framed around MARPOL Annex I oily-water limits, the Navigation Act 2012 and the Marine Pollution Prevention Act 1999, with additional state and territory rules for protected waters. Ships around Australia must also manage waste reception, record keeping and accidental pollution under applicable Commonwealth and maritime rules. Pathogen-specific bilge limits are less consistent across jurisdictions, so evidence of inactivation can complement existing oil and chemical controls without replacing them.
How electrochemistry and membranes inactivate contaminants
In an electrochemical reactor, the anode can oxidise chloride or dissolved organic compounds, while the cathode supports hydrogen evolution and can generate low-level hydrogen peroxide through a suitable two-electron pathway. Depending on pH, salinity, current density and residence time, the resulting active chlorine, peroxide or other reactive species can damage cell membranes, enzymes and nucleic acids. Direct electrical effects and membrane-associated oxidation may add to this chemical action.
The membrane bioreactor is more than a barrier. It retains biomass and extracellular polymeric substances, limits electrode fouling and creates a controlled contact zone between microorganisms and the electric field. The ElectroSAnMBR discussion of electroactive biofilm support explains how a membrane can provide a stable surface for electroactive communities. Such a biofilm may consume soluble organics, alter local redox conditions and help keep catalytic sites active, although those functions must be measured rather than assumed.
Anaerobic digestion addresses a different fraction of the problem by converting readily biodegradable organics into methane and carbon dioxide. It can lower the organic load reaching the disinfection stage and reduce membrane fouling, but it does not guarantee pathogen inactivation. Process architecture, electrode placement and oxidant exposure must be designed so that digestion conditions do not neutralise the disinfecting species. Flow-through trials should therefore report both organic removal and microbial reduction.
Evidence needed for marine bacteria and pathogens
A credible study needs challenge organisms and controls that reflect marine exposure. Candidate targets include enterococci and Escherichia coli as enteric indicators, alongside species or strains of Vibrio, Aeromonas and Salmonella where they are relevant to the vessel route. Culture methods establish viable counts, while qPCR or dPCR can quantify genetic targets; viability assays are needed because DNA from dead cells can still produce a positive signal. No single method captures every bacterium, virus or protozoan.
Saline, oily or metal-rich bilge can inhibit recovery and alter both culture and molecular assays, so matrix-matched controls are essential. Where outside information is cited, even a page labelled independent test protocols should be appraised for authorship, methods and relevance instead of accepted on its label alone. The same discipline applies to every treatment claim: log reduction, detection limit and uncertainty must be tied to a reproducible protocol.
Core experimental controls
- Untreated bilge-water control and inoculated clean-water control
- The same matrix treated without electricity to isolate chemical effects
- Sterile-medium and reagent blanks for contamination
- Organism recovery controls and checks of membrane integrity
- Sampling across current, voltage, pH, salinity and temperature
- Measurements of residual oxidant, energy, electrode wear and flux
Together, these controls distinguish true killing from temporary growth inhibition, re-growth after treatment and loss of organisms through filtration or sampling. Spiking studies can be followed by recovery in clean bilge water, while continuous trials test whether the reactor retains performance when incoming organic matter and biofilm change.
From laboratory validation to Australian deployment
Australian deployment should begin with real vessel samples and realistic operating envelopes. A unit intended for a coastal ferry has different footprint, power and maintenance constraints from a system serving a fishing vessel or offshore facility. Portable skids, automatic control, safe chemical handling and easy electrode replacement will matter as much as laboratory log reduction. Local operators can identify fouling patterns and peak waste loads that a generic synthetic matrix may miss.
Communications should make the evidence as traceable as the treatment itself. A promotional page built around trusted bonus comparisons, for example, shows why incentives and polished claims cannot substitute for peer-reviewed methods, controls and uncertainty. The same standard applies to environmental technology: publish the operating window, maintenance needs and failure modes alongside removal performance, and distinguish measured results from projections.
Practical priorities for an Australian trial
- Sampling with cooperation from vessels using Sydney, Melbourne, Brisbane or Fremantle
- Testing fresh, brackish and full-salinity water from varied ship types
- Spiking with representative marine bacteria and relevant enteric pathogens
- Challenging feeds with fuel oil, detergents, antifouling residues and metals
- Running warm and cool tests alongside continuous-flow durability trials
- Recording energy, membrane flux, electrode wear, sludge and microbiological trends
Trial governance should follow MARPOL, Commonwealth law and the relevant state or territory requirements, with discharge decisions based on oil and chemical limits as well as the new microbiological evidence. Reception-facility procedures and accidental-release plans should be built into shipboard operation. Biosecurity approval and quarantine requirements may also apply when non-native strains or biological materials enter Australia, although routine in-country sampling follows different pathways.
Turn evidence into a working treatment system
The next stage is a collaborative Australian validation campaign linking vessel operators, microbiologists, electrochemists, membrane manufacturers, regulators and the ElectroSAnMBR research team and affiliated laboratories. Participants can contribute bilge-water samples, local temperature and salinity data, shipboard space or analytical capacity, while the project supplies integrated treatment design and performance assessment. Work packages should connect benchtop inoculation, continuous-flow trials and pilot deployment so that each result has a clear route into operational decisions.
Act now by contacting the project about the next experimental campaign and identifying a vessel, laboratory or test site that can contribute representative samples and operating data. The immediate goal is a treatment train that can be monitored, maintained and defended with traceable evidence in Australian waters. Join the campaign to help convert promising electrochemical inactivation into a practical safeguard for ports, coastlines and the communities that depend on them.